ACCELERATE DIAGNOSTICS INC's ticker is and the CUSIP is 00430HAB8. A total of 15 filers reported holding ACCELERATE DIAGNOSTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $25,173,000 | -34.2% | 38,655,000 | -29.6% | 0.01% | -25.0% |
| Q1 2022 | $38,255,000 | -15.9% | 54,905,000 | -9.5% | 0.01% | -11.1% |
| Q4 2021 | $45,465,000 | -2.5% | 60,655,000 | -7.6% | 0.01% | -10.0% |
| Q3 2021 | $46,617,000 | +7.3% | 65,655,000 | -1.5% | 0.01% | 0.0% |
| Q2 2021 | $43,446,000 | -2.5% | 66,655,000 | 0.0% | 0.01% | -9.1% |
| Q1 2021 | $44,578,000 | +15.2% | 66,655,000 | 0.0% | 0.01% | +10.0% |
| Q4 2020 | $38,695,000 | -9.9% | 66,655,000 | -1.5% | 0.01% | -16.7% |
| Q3 2020 | $42,941,000 | -6.2% | 67,655,000 | +6.3% | 0.01% | -25.0% |
| Q2 2020 | $45,781,000 | +46.9% | 63,655,000 | +13.0% | 0.02% | +14.3% |
| Q1 2020 | $31,159,000 | -20.4% | 56,350,000 | +12.4% | 0.01% | -17.6% |
| Q4 2019 | $39,152,000 | -6.6% | 50,150,000 | 0.0% | 0.02% | -15.0% |
| Q3 2019 | $41,940,000 | -7.6% | 50,150,000 | 0.0% | 0.02% | -4.8% |
| Q2 2019 | $45,386,000 | – | 50,150,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cowen Prime Advisors LLC | 7,580,000 | $5,330,000 | 1.98% |
| Samjo Capital LLC | 2,600,000 | $1,828,000 | 1.34% |
| PenderFund Capital Management Ltd. | 5,560,000 | $5,031,000 | 1.32% |
| Indaba Capital Management, L.P. | 11,000,000 | $7,698,000 | 0.82% |
| Saltoro Capital, LP | 900,000 | $642,000 | 0.23% |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 8,000,000 | $5,625,000 | 0.08% |
| WOLVERINE ASSET MANAGEMENT LLC | 4,000,000 | $2,814,000 | 0.02% |
| INGALLS & SNYDER LLC | 815,000 | $532,000 | 0.02% |
| BlueCrest Capital Management Ltd | 1,000,000 | $662,000 | 0.02% |
| Citadel Advisors | 65,655,000 | $46,617,000 | 0.01% |